HDR Gateway logo
HDR Gateway logo

Bookmarks

R25 - A phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 (COV002)

Safe People

Organisation name

University of Oxford

Organisation sector

Academic Institute

Safe Projects

Project ID

DARS-NIC-381633-K9Y2T-v2.4

Latest approval date

21/04/2021

Safe Data

Dataset(s) name
Data sensitivity level

De-Personalised

Legal basis for provision of data under Article 6

CV19: Regulation 3 (4) of the Health Service (Control of Patient Information) Regulations 2002; Health and Social Care Act 2012 - s261 - 'Other dissemination of information'

National data opt-out applied?

Statutory exemption to flow confidential data without consent

Request frequency

One-Off

Safe Setting

Access type

TRE